Mesalamin

( DrugBank: - / KEGG DRUG: - )

1 disease

告示番号	疾患名（ページ内リンク）	臨床試験数
97	潰瘍性大腸炎	100

97. 潰瘍性大腸炎

臨床試験数 : 2,630 / 薬物数 : 1,459 - (DrugBank : 265) / 標的遺伝子数 : 144 - 標的パスウェイ数 : 202

trials per page:

Showing 1 to 10 of 100 trials

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT05753267 (ClinicalTrials.gov)	February 28, 2023	22/2/2023	Fenofibrate in Ulcerative Colitis	Clinical Study to Evaluate the Possible Efficacy of Fenofibrate in Patient With Ulcerative Colitis	Inflammatory Bowel Diseases	Drug: Mesalamine;Drug: Fenofibrate 160mg	Tanta University	Eman Ibrahim Elberri, Faculty of Pharmacy, Tanta University;Hend El-Said Abo Mansour, Faculty of Pha ...	Recruiting	18 Years	75 Years	All	60	Phase 2/Phase 3	Egypt
2	NCT05567068 (ClinicalTrials.gov)	February 1, 2023	1/10/2022	Atorvastatin Efficacy and Safety in Patients With Ulcerative Colitis	Repurposing Atorvastatin in Patients With Ulcerative Colitis Treated With Mesalamine by Modulation o ...	Inflammatory Bowel Diseases	Drug: Atorvastatin 80mg;Drug: Mesalamine	Tanta University	NULL	Not yet recruiting	18 Years	75 Years	All	44	Phase 2	NULL
3	NCT05574387 (ClinicalTrials.gov)	January 20, 2023	6/10/2022	Metformin as Added on Therapy in Patients With Ulcerative Colitis	Metformin, The Biguanide Derivative, as Adjuvant Therapy in Patients With Ulcerative Colitis Treated ...	Inflammatory Bowel Diseases	Drug: Metformin	Tanta University	Principal Investigator Sahar El-Haggar, Prof Clinical pharmacy Department- Tanta University;Principa ...	Recruiting	18 Years	75 Years	All	46	Phase 2	Egypt
4	NCT05316220 (ClinicalTrials.gov)	December 31, 2022	31/3/2022	A Study to Assess Adverse Events and Change in Disease Condition of Mesalamine Capsules in Children ...	A Randomized, Double-blind Study to Assess the Safety and Efficacy of Mesalamine Delayed-release Cap ...	Ulcerative Colitis (UC)	Drug: Mesalamine;Drug: Placebo	AbbVie	NULL	Not yet recruiting	5 Years	17 Years	All	80	Phase 3	United States;Puerto Rico
5	NCT05553704 (ClinicalTrials.gov)	November 1, 2022	20/9/2022	Metformin in Patients With Ulcerative Colitis Treated With Mesalamine	Clinical Study to Compare the Possible Efficacy of Metformin in Patients With Ulcerative Colitis Tre ...	Inflammatory Bowel Diseases	Drug: Metformin	Tanta University	NULL	Recruiting	18 Years	75 Years	All	52	Phase 2	Egypt
6	NCT05626166 (ClinicalTrials.gov)	November 2022	9/11/2022	the Efficacy and Safety of Diosmin in Patients With Ulcerative Colitis	Clinical Study Evaluating the Efficacy and Safety of Diosmin in Patients With Ulcerative Colitis Tre ...	Ulcerative Colitis	Drug: Placebo;Drug: Diosmin	Tanta University	NULL	Not yet recruiting	18 Years	N/A	All	60	Phase 3	NULL
7	NCT05558761 (ClinicalTrials.gov)	October 10, 2022	25/9/2022	Pentoxifylline as Adjunctive Therapy in Patients With Ulcerative Colitis	Clinical Study to Evaluate the Possible Efficacy of Pentoxifylline in Patients With Ulcerative Colit ...	Inflammatory Bowel Diseases	Drug: Pentoxifylline 400 MG	Tanta University	NULL	Recruiting	18 Years	75 Years	All	50	Phase 2	Egypt
8	NCT05119140 (ClinicalTrials.gov)	June 10, 2022	20/10/2021	HCQ for Non Europeans With Mild to Severe UC	Administration of Hydroxychloroquine (Plaquenil) to Individuals of Non-European Ancestry for the Tre ...	Ulcerative Colitis (Disorder)	Drug: Hydroxychloroquine;Drug: Mesalamine	Icahn School of Medicine at Mount Sinai	Crohn's and Colitis Foundation	Recruiting	18 Years	N/A	All	20	Phase 1/Phase 2	United States
9	ChiCTR2000037261	2020-10-01	2020-08-27	Study on the clinic of stasis removing and renewal therapy for ulcerative colitis based on serum exo ...	Study on the clinic of stasis removing and renewal therapy for ulcerative colitis based on serum exo ...	Ulcerative Colitis	experimental group:stasis removing and immunoregulation therapy;control group:mesalamine;	Yueyang Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai University of Trad ...	NULL	Recruiting	18	65	Both	experimental group:30;control group:30;		China
10	NCT03923478 (ClinicalTrials.gov)	June 24, 2019	15/4/2019	ABI-M201 in Adult Subjects With Mildly-to-Moderately Active Ulcerative Colitis	A Randomized, Double-Blind, Placebo-Controlled, Multi-Center Phase 1b Study to Evaluate the Safety, ...	Ulcerative Colitis Chronic Mild;Ulcerative Colitis Chronic Moderate	Drug: ABI-M201;Drug: Placebo	Assembly Biosciences	NULL	Terminated	18 Years	70 Years	All	15	Phase 1	United States;Canada

First Previous1 2 3 4 5…10Next Last